E-LIB Suche - Ergebnisse für: Gundesen, Michael T.

1

Potential value of pre-planned imaging of bone disease in m..:

Gundesen, Michael T. ; Asmussen, Jon Thor ; Schjesvold, Fredrik...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

2

A prospective study of Skeletal survey versus Low‐dose whol..:

Gundesen, Michael T. ; Asmussen, Jon T. ; Haukås, Einar...
European Journal of Haematology. 108 (2022) 5 - p. 423-429 , 2022

Link: https://doi.org/10.1111/..

3

Potential value of pre-planned imaging of bone disease in m..:

Gundesen, Michael T ; Asmussen, Jon Thor ; Schjesvold, Fredrik...
Gundesen , M T , Asmussen , J T , Schjesvold , F , Vangsted , A J , Helleberg , C , Haukås , E , Silkjær , T , Teodorescu , E M , Jensen , B A , Slørdahl , T S , Nahi , H , Waage , A , Abildgaard , N , Lund , T & Nordic Myeloma Study Group 2023 , ' Potential value of pre-planned imaging of bone disease in multiple myeloma ' , Blood Cancer Journal , vol. 13 , no. 1 , 105 . https://doi.org/10.1038/s41408-023-00880-0. , 2023

Link: https://pure.au.dk/porta..

4

Potential value of pre-planned imaging of bone disease in m..:

Gundesen, Michael T ; Asmussen, Jon Thor ; Schjesvold, Fredrik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328913/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Potential value of pre-planned imaging of bone disease in m..:

Gundesen, Michael T ; Asmussen, Jon Thor ; Schjesvold, Fredrik...
https://vbn.aau.dk/da/publications/8057aed7-cf72-48b1-b3a8-48a7741eecac. , 2023

Link: https://vbn.aau.dk/da/pu..

6

Potential value of pre-planned imaging of bone disease in m..:

Michael T. Gundesen ; Jon Thor Asmussen ; Fredrik Schjesvold...
https://doi.org/10.1038/s41408-023-00880-0. , 2023

Link: https://doi.org/10.1038/..

7

In multiple myeloma, monthly treatment with zoledronic acid..:

Lund, Thomas ; Gundesen, Michael Tveden ; Juul Vangsted, Annette...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

8

Bone marrow adipocytes provide early sign for progression f..:

El-Masri, Bilal M. ; Leka, Benedeta ; Mustapha, Fatima...
Oncotarget. 15 (2024) 1 - p. 20-26 , 2024

Link: https://doi.org/10.18632..

9

Novel Developments in the Treatment of Multiple Myeloma-Ass..:

Johansen, Martin ; Levring, Mette Bøegh ; Stokbro, Kasper...
Cancers. 15 (2023) 23 - p. 5585 , 2023

Link: https://doi.org/10.3390/..

10

Home is best. Self-administration of subcutaneous Bortezomi..:

Kirkegaard, Jannie ; Lundholm, Birgitte Wolf ; Rosenberg, Tine...
European Journal of Oncology Nursing. 60 (2022) - p. 102199 , 2022

Link: https://doi.org/10.1016/..

11

Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Mo..:

Diaz-delCastillo, Marta ; Gundesen, Michael Tveden ; Andersen, Christian Walther...
Journal of Bone and Mineral Research. 38 (2020) 5 - p. 639-649 , 2020

Link: https://doi.org/10.1002/..

12

Plasma Cell Leukemia: Definition, Presentation, and Treatme..:

Gundesen, Michael Tveden ; Lund, Thomas ; Moeller, Hanne E. H..
Current Oncology Reports. 21 (2019) 1 - p. , 2019

Link: https://doi.org/10.1007/..

13

High levels of c-Met is associated with poor prognosis in g..:

Petterson, Stine Asferg ; Dahlrot, Rikke Hedegaard ; Hermansen, Simon Kjær...
Journal of Neuro-Oncology. 122 (2015) 3 - p. 517-527 , 2015

Link: https://doi.org/10.1007/..

14

P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLE..:

Gundesen, Michael ; Schjesvold, Fredrik ; Vangsted, Annette...
HemaSphere. 7 (2023) S3 - p. e014785b , 2023

Link: https://doi.org/10.1097/..

15

OA-10 Four years treatment with zoledronic acid is superior..:

Gundesen, Michael ; Schjesvold, Fredrik ; Vangsted, Annette Juul...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S6-S7 , 2023

Link: https://doi.org/10.1016/..